Lightcast Discovery
Cambridge
About Lightcast Discovery
Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products. The company's mission is to push the boundaries of complex cell analysis. Using the Lightcast platform, the company is working with major pharmaceutical companies and leading academic institutes to enable them to discover more. The Lightcast platform allows precise and highly flexible independent control of thousands of droplets. By combining droplets containing different cells, reporters or other reagents we can perform complex workflows without the need to manipulate cells by hand. Lightcast Discovery was founded in 2019 by Cameron Frayling.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $50.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2023)
- Website: lightcast.bio
- Phone: +44 (0)1223 362778
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/lightcast-discovery-3581 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.